In the present study, therefore, we aimed to investigate the long-term effects of a ghrelin agonist given for 4 months on Alzheimer’s disease pathology, cognition, and metabolism in the same mouse model fed a high–glycemic index (GI) diet as a constant challenge for glucose homeostasis. Here, GHRL is linked to Alzheimer disease.